NRIX Stock Analysis: Buy, Sell, or Hold?

NRIX - Nurix Therapeutics, Inc. Common stock

PHARMACEUTICAL PREPARATIONS
$16.52
-1.07 (-6.08%) ▼
WAIT
LOW Confidence
Protect Your NRIX Gains
Last Updated: January 30, 2026
Earnings: Apr 14, 2026

Get Alerted When NRIX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NRIX is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: NRIX is currently trading at $16.52, which is considered oversold relative to its 30-day fair value range of $17.92 to $19.39.

Technical Outlook: Technically, NRIX is in a strong uptrend. The price is currently testing key support at $16.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.1% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.59 (+68.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $17.92 - $19.39
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Protect Your Profits

Holding NRIX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.1%)
  • BULLISH: Trading 68.2% below Wall St target ($29.59)
  • WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $17.92 - $19.39
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $16.56
Resistance Level $20.18
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -5.09
Wall Street Target $29.59 (+68.2%)
Revenue Growth (YoY) -37.3%
Profit Margin -292.5%
Last updated: January 31, 2026 1:19 AM ET
Data refreshes hourly during market hours. Next update: 2:19 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 59 HOLD
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$22 60 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$83 57 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 59 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$141 59 HOLD

Advanced NRIX Option Strategies

Professional options setups generated by AI based on today's NRIX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NRIX

NRIX Technical Chart NRIX Price Prediction NRIX Earnings Date NRIX Investment Advisor NRIX Fair Price Analyzer NRIX Options Advisor NRIX Options Chain NRIX Options Analysis NRIX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals